Glancy prongay & murray llp continues investigation on behalf of solid biosciences inc. investors (sldb)

Los angeles--(business wire)--glancy prongay & murray llp (“gpm”) continues its investigation on behalf of solid biosciences inc. (“solid biosciences” or the “company”) (nasdaq: sldb) investors concerning the company and its officers’ possible violations of federal securities laws. if you purchased solid biosciences securities, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact lesley portnoy, esquire, of gpm, 1925 century park east, suite 2100, los angeles, california 90067 at 310-201-9150, toll-free at 888-773-9224, by email to shareholders@glancylaw.com, or visit our website at www.glancylaw.com. if you inquire by email please include your mailing address, telephone number and number of shares purchased. this press release may be considered attorney advertising in some jurisdictions under the applicable law and ethical rules.
SLDB Ratings Summary
SLDB Quant Ranking